Reduction of T Lymphoma Cells and Immunological Invigoration in a Patient Concurrently Affected by Melanoma and Sezary Syndrome Treated With Nivolumab

Despite the recent availability of several new drugs in hemato-oncology, T-cell lymphomas are still incurable and PD-1 blockade could represent a therapeutic chance for selected patients affected by these malignancies, although further studies are required to understand the biological effects of ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Narducci, Maria Grazia, Tosi, Anna, Frezzolini, Alessandra, Scala, Enrico, Passarelli, Francesca, Bonmassar, Laura, Monopoli, Alessandro, Accetturi, Maria Pina, Cantonetti, Maria, Antonini Cappellini, Gian Carlo, De Galitiis, Federica, Rosato, Antonio, Picozza, Mario, Russo, Giandomenico, D’Atri, Stefania
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7544958/
https://www.ncbi.nlm.nih.gov/pubmed/33072126
http://dx.doi.org/10.3389/fimmu.2020.579894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7544958/
https://www.ncbi.nlm.nih.gov/pubmed/33072126
http://dx.doi.org/10.3389/fimmu.2020.579894

Ejemplares similares